Is my portfolio
One Report to Answer all your Questions!
Alivus Life Sciences Ltd.
BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
900.20
10.60 (1.19%) Glenmark Life Sciences informs about disclosure
Date: 26-09-2023Glenmark Life Sciences has informed that it enclosed the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirma.
The above information is a part of company’s filings submitted to BSE.